ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,065 | +39.7% | 1,771 | +58.3% | 0.00% | +100.0% |
| Q2 2023 | $34,398 | +5.6% | 1,119 | +23.8% | 0.00% | 0.0% |
| Q1 2023 | $32,571 | +405.6% | 904 | +454.6% | 0.00% | – |
| Q4 2022 | $6,442 | -57.1% | 163 | -56.8% | 0.00% | -100.0% |
| Q3 2022 | $15,000 | +114.3% | 377 | +116.7% | 0.00% | – |
| Q2 2022 | $7,000 | -36.4% | 174 | -40.8% | 0.00% | – |
| Q1 2022 | $11,000 | +10.0% | 294 | +13.1% | 0.00% | – |
| Q4 2021 | $10,000 | +900.0% | 260 | +642.9% | 0.00% | – |
| Q3 2021 | $1,000 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |